Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of Kansas
1247
mi
from 02139
Kansas City, KA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of Kansas
1247
mi
from 02139
Kansas City, KA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of Kentucky
766
mi
from 02139
Lexington, KY
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of Kentucky
766
mi
from 02139
Lexington, KY
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
356
mi
from 02139
Baltimore, MD
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
356
mi
from 02139
Baltimore, MD
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
2
mi
from 02139
Boston, MA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Boston University
2
mi
from 02139
Boston, MA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Boston University
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of Michigan at Ann Arbor
643
mi
from 02139
Ann Arbor, MI
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of Michigan at Ann Arbor
643
mi
from 02139
Ann Arbor, MI
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
1079
mi
from 02139
Rochester, MN
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
1079
mi
from 02139
Rochester, MN
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Lou Ruvo Center for Brain Health
2367
mi
from 02139
Las Vegas, NV
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Lou Ruvo Center for Brain Health
2367
mi
from 02139
Las Vegas, NV
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Dartmouth Medical Center
105
mi
from 02139
Lebanon, NH
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Dartmouth Medical Center
105
mi
from 02139
Lebanon, NH
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Albany Medical College
136
mi
from 02139
Albany, NY
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Albany Medical College
136
mi
from 02139
Albany, NY
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
DENT Neurologic Institute
393
mi
from 02139
Amherst, NY
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
DENT Neurologic Institute
393
mi
from 02139
Amherst, NY
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Columbia University
180
mi
from 02139
New York, NY
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Columbia University
180
mi
from 02139
New York, NY
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Nathan S. Kline Institute for Psychiatric Research
172
mi
from 02139
Orangeburg, NY
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Nathan S. Kline Institute for Psychiatric Research
172
mi
from 02139
Orangeburg, NY
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Univ of Rochester Medical Center
335
mi
from 02139
Rochester, NY
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Univ of Rochester Medical Center
335
mi
from 02139
Rochester, NY
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
601
mi
from 02139
Durham, NC
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
601
mi
from 02139
Durham, NC
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Health Sciences
654
mi
from 02139
Winston-Salem, NC
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Health Sciences
654
mi
from 02139
Winston-Salem, NC
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve University
538
mi
from 02139
Beachwood, OH
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve University
538
mi
from 02139
Beachwood, OH
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Ohio State University
640
mi
from 02139
Columbus, OH
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Ohio State University
640
mi
from 02139
Columbus, OH
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
2530
mi
from 02139
Portland, OR
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
2530
mi
from 02139
Portland, OR
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
270
mi
from 02139
Philadelphia, PA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
270
mi
from 02139
Philadelphia, PA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh
477
mi
from 02139
Pittsburgh, PA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh
477
mi
from 02139
Pittsburgh, PA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
41
mi
from 02139
Providence, RI
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
41
mi
from 02139
Providence, RI
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Butler Hospital Memory & Aging Program
40
mi
from 02139
Providence, RI
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Butler Hospital Memory & Aging Program
40
mi
from 02139
Providence, RI
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
1546
mi
from 02139
Dallas, TX
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
1546
mi
from 02139
Dallas, TX
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
1601
mi
from 02139
Houston, TX
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
1601
mi
from 02139
Houston, TX
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin
929
mi
from 02139
Madison, WI
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin
929
mi
from 02139
Madison, WI
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
2692
mi
from 02139
San Francisco, CA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
2692
mi
from 02139
San Francisco, CA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic, Jacksonville
1016
mi
from 02139
Jacksonville, FL
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic, Jacksonville
1016
mi
from 02139
Jacksonville, FL
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
USF Health Byrd Alzheimer's Institute
1174
mi
from 02139
Tampa, FL
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
USF Health Byrd Alzheimer's Institute
1174
mi
from 02139
Tampa, FL
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Emory University
934
mi
from 02139
Atlanta, GA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Emory University
934
mi
from 02139
Atlanta, GA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Northwestern University
845
mi
from 02139
Chicago, IL
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Northwestern University
845
mi
from 02139
Chicago, IL
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
New York Univ. Medical Center
188
mi
from 02139
New York, NY
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
New York Univ. Medical Center
188
mi
from 02139
New York, NY
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Mount Sinai School of Medicine
182
mi
from 02139
New York, NY
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Mount Sinai School of Medicine
182
mi
from 02139
New York, NY
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Roper St. Francis Healthcare
815
mi
from 02139
North Charleston, SC
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Roper St. Francis Healthcare
815
mi
from 02139
North Charleston, SC
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of British Columbia, Clinic for Alzheimer's Disease and Related Disorders Program
2498
mi
from 02139
Vancouver,
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of British Columbia, Clinic for Alzheimer's Disease and Related Disorders Program
2498
mi
from 02139
Vancouver,
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Washington University in St. Louis
1037
mi
from 02139
Saint Louis, MO
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Washington University in St. Louis
1037
mi
from 02139
Saint Louis, MO
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Georgetown University
392
mi
from 02139
Washington,
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Georgetown University
392
mi
from 02139
Washington,
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Howard University
390
mi
from 02139
Washington,
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Howard University
390
mi
from 02139
Washington,
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Banner Alzheimer'S Institute
2290
mi
from 02139
Phoenix, AZ
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Banner Alzheimer'S Institute
2290
mi
from 02139
Phoenix, AZ
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
The University of California, San Diego
2577
mi
from 02139
La Jolla, CA
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
The University of California, San Diego
2577
mi
from 02139
La Jolla, CA
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Pacific Neuroscience Med Grp
2629
mi
from 02139
Oxnard, CA
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Pacific Neuroscience Med Grp
2629
mi
from 02139
Oxnard, CA
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Yale University ADRU
119
mi
from 02139
New Haven, CT
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Yale University ADRU
119
mi
from 02139
New Haven, CT
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Brain Matters Research
1211
mi
from 02139
Delray Beach, FL
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Brain Matters Research
1211
mi
from 02139
Delray Beach, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Infinity Clinical Research, LLC
1241
mi
from 02139
Hollywood, FL
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Infinity Clinical Research, LLC
1241
mi
from 02139
Hollywood, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Roskamp Institute
1216
mi
from 02139
Sarasota, FL
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Roskamp Institute
1216
mi
from 02139
Sarasota, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Compass Research
1110
mi
from 02139
The Villages, FL
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Compass Research
1110
mi
from 02139
The Villages, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Premiere Research Institute
1191
mi
from 02139
West Palm Beach, FL
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Premiere Research Institute
1191
mi
from 02139
West Palm Beach, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Atlanta Center for Medical Research
932
mi
from 02139
Atlanta, GA
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Atlanta Center for Medical Research
932
mi
from 02139
Atlanta, GA
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Indiana University
804
mi
from 02139
Indianapolis, IN
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Indiana University
804
mi
from 02139
Indianapolis, IN
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated:  12/31/1969
Boston Center for Memory
5
mi
from 02139
Newton, MA
A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Two Year Study to Evaluate the Effect of Subcutaneous RO4909832 on Cognition and Function in Prodromal Alzheimer's Disease With Option for up to an Additional Two Years of Treatment and an Open-Label Extension With Active Study Treatment
Status: Enrolling
Updated: 12/31/1969
Boston Center for Memory
5
mi
from 02139
Newton, MA
Click here to add this to my saved trials